ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,084.61
-0.26%
Dow Jones
42,840.26
1.18%
Gold vs US Dollar
2,623.175
0.00%
Brent Oil
72.72
0.00%
Bitcoin
96,500.01
-0.73%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Telomir Pharmaceuticals Inc (TELO)

  7. Telomir Pharmaceuticals Inc (TELO) News

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TELO
DateTimeSourceHeadlineSymbolCompany
20/12/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
11/12/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
02/12/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
25/11/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELOTelomir Pharmaceuticals Inc
21/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
20/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
12/11/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
27/09/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
12/08/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanNASDAQ:TELOTelomir Pharmaceuticals Inc
02/07/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap IndexesNASDAQ:TELOTelomir Pharmaceuticals Inc
17/06/202420:10GlobeNewswire Inc.Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting PanelNASDAQ:TELOTelomir Pharmaceuticals Inc
30/05/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1NASDAQ:TELOTelomir Pharmaceuticals Inc
24/05/202413:30GlobeNewswire Inc.New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ETNASDAQ:TELOTelomir Pharmaceuticals Inc
16/05/202413:30GlobeNewswire Inc.Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial SupportNASDAQ:TELOTelomir Pharmaceuticals Inc
13/05/202420:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
16/04/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.NASDAQ:TELOTelomir Pharmaceuticals Inc
02/04/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024NASDAQ:TELOTelomir Pharmaceuticals Inc
29/03/202420:44GlobeNewswire Inc.UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
26/03/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
22/03/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thNASDAQ:TELOTelomir Pharmaceuticals Inc
14/03/202412:30GlobeNewswire Inc.Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal ScienceNASDAQ:TELOTelomir Pharmaceuticals Inc
07/03/202413:30GlobeNewswire Inc.Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceNASDAQ:TELOTelomir Pharmaceuticals Inc
05/03/202413:30GlobeNewswire Inc.Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalNASDAQ:TELOTelomir Pharmaceuticals Inc
13/02/202421:05GlobeNewswire Inc.Telomir Pharmaceuticals Announces Closing of Initial Public OfferingNASDAQ:TELOTelomir Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TELO

Your Recent History

LSE
SYME
Supply@me Capital
LSE
BARC
Barclays
LSE
MIN
Minoan
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
ASC
Asos
LSE
STX
Shield Therapeutics
LSE
ITV
Itv
LSE
OCDO
Ocado
LSE
BBGI
Bbgi Global Infrastructure
LSE
THUS
Thus
LSE
ITM
Itm Power
LSE
PLUS
Plus500
LSE
BOO
Boohoo
LSE
INSG
Insig Ai
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads